scispace - formally typeset
W

Wen Zheng

Researcher at Sichuan University

Publications -  21
Citations -  297

Wen Zheng is an academic researcher from Sichuan University. The author has contributed to research in topics: Medicine & Metabolomics. The author has an hindex of 5, co-authored 13 publications receiving 84 citations.

Papers
More filters
Journal ArticleDOI

Targeting Mitochondria-Inflammation Circuit by β-Hydroxybutyrate Mitigates HFpEF

TL;DR: The interplay of mitochondrial hyperacetylation and inflammation as a key driver in HFpEF pathogenesis is identified and can be ameliorated by promoting β-hydroxybutyrate abundance.
Journal ArticleDOI

MetaboGroupS: A Group Entropy-Based Web Platform for Evaluating Normalization Methods in Blood Metabolomics Data from Maintenance Hemodialysis Patients

TL;DR: A powerful and user-friendly web platform, named MetaboGroup S, is presented for comparison and evaluation of seven popular normalization methods and provides an optimal one automatically for end users based on the group entropies of every sample data point.
Journal ArticleDOI

MixProTool: A Powerful and Comprehensive Web Tool for Analyzing and Visualizing Multigroup Proteomics Data.

TL;DR: This work develops a free interactive web software platform, MixProTool, for processing multigroup proteomics data sets, which provides integrated data analysis workflow, including quality control assessment, normalization, soft independent modeling of class analogy, statistics, gene ontology enrichment, and Kyoto Encyclopedia of Genes and Genomes pathway enrichment analysis.
Journal ArticleDOI

Investigating the effect of Ti3C2 (MXene) nanosheet on human umbilical vein endothelial cells via a combined untargeted and targeted metabolomics approach

TL;DR: Results indicated that —high concentrations (500 mg/L) of MXene can cause significant changes in the energy metabolism of HUVECs, showing obvious inhibition of tricarboxylic acid (TCA) cycle with the enhancement of glycolysis, fatty acid biosynthesis, and lipid accumulation.
Journal ArticleDOI

Small hepatitis delta antigen selectively binds to target mRNA in hepatic cells: a potential mechanism by which hepatitis D virus downregulates glutathione S-transferase P1 and induces liver injury and hepatocarcinogenesis.

TL;DR: A novel potential mechanism of HDV-induced liver injury and hepatocarcinogenesis is revealed: s-HDAg can inhibit GSTP1 expression by directly binding to GSTP 1 mRNA, which leads to accumulation of cellular ROS, resulting in high cellular apoptotic ratios and increased selective pressure for malignant transformation.